financetom
Business
financetom
/
Business
/
Canopy Growth Stock Is Ripping Higher: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canopy Growth Stock Is Ripping Higher: What's Going On?
Mar 26, 2024 9:33 AM

Canopy Growth Corp ( CGC ) shares are trading higher Tuesday, adding to gains of more than 100% over the last week. Here’s a look at what’s going on.

What To Know: Canopy Growth ( CGC ) shares appear to be rising on continued momentum following the legalization of adult-use cannabis in Germany last week.

Germany passed a law on Friday that will allow individuals to possess up to 25 grams of cannabis for personal consumption, store up to 50 grams in their homes and maintain up to three plants for home cultivation. The new law is set to go into effect on April 1.

In a press release responding to the news, Canopy Growth ( CGC ) called the legalization a “monumental shift” in the legal treatment and cultural acceptance of cannabis. The company also noted that the legalization has created an opportunity for Canopy to expand its commercial presence in the country through its German-based vaporizer brand Storz & Bickel, as well as through the company’s medical cannabis product offerings.

Check This Out: 63% Of Americans Support Cannabis Banking Reform Amid Congressional Push: American Bankers Association

For Canopy Medical, the classification of cannabis as a non-narcotic is expected to result in more patients engaging with their physicians about medical cannabis options.

“The re-classification of cannabis as a non-narcotic is a game-changer for patients and physicians who will be empowered to better explore cannabis as a viable treatment option for an expanded range of condition,” said Tara Rozalowsky, chief growth officer and president, International, Canopy Growth ( CGC ).

“We are thrilled to be able to continue serving the medical community by delivering high-quality cannabis products that meet patient needs and we look forward to increasing our already leading presence in the German medical cannabis market.”

Despite more than doubling in recent sessions, Canopy growth shares are still down more than 98% over the last five years. Canopy Growth ( CGC ) stock is trending across various social platforms Tuesday as retail traders discuss a potential turnaround in the stock.

Canopy Growth’s average session volume is about 5.4 million, according to Benzinga Pro. Tuesday’s trading volume has already exceeded 31 million at publication time.

See Also: Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday

CGC Price Action: Canopy Growth ( CGC ) shares were up 26% at $7.81 at the time of publication, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alibaba Gr Hldgs Unusual Options Activity For February 13
Alibaba Gr Hldgs Unusual Options Activity For February 13
Feb 13, 2025
Financial giants have made a conspicuous bullish move on Alibaba Gr Hldgs. Our analysis of options history for Alibaba Gr Hldgs revealed 12 unusual trades. Delving into the details, we found 41% of traders were bullish, while 41% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $84,100, and 10 were calls,...
IDEAYA Biosciences Launching Gilead Trial Collaboration to Evaluate Trodelvy, IDE397 Combination in Lung Cancer
IDEAYA Biosciences Launching Gilead Trial Collaboration to Evaluate Trodelvy, IDE397 Combination in Lung Cancer
Feb 13, 2025
10:09 AM EST, 02/13/2025 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Thursday it has signed an additional clinical trial collaboration and supply agreement with Gilead Sciences ( GILD ) to assess the efficacy and safety of IDE397 plus Gilead's Trodelvy in methylthioadenosine phosphorylase-deletion, or MTAP-deletion, non-small cell lung cancer. The drugmakers will include patients with lung cancer in...
Update: Phinia Q4 Adjusted Earnings, Net Sales Fall; 2025 Sales Guidance Issued
Update: Phinia Q4 Adjusted Earnings, Net Sales Fall; 2025 Sales Guidance Issued
Feb 13, 2025
10:01 AM EST, 02/13/2025 (MT Newswires) -- (Updates with dividend, stock repurchase and latest stock move starting in the sixth paragraph.) Phinia ( PHIN ) reported Q4 adjusted net earnings Thursday of $0.71 per diluted share, down from $0.76 a year earlier. Four analysts surveyed by FactSet expected EPS of $0.87. Net sales for the quarter were $833 million, down...
International Paper to Permanently Shut Down Multiple US Facilities by April
International Paper to Permanently Shut Down Multiple US Facilities by April
Feb 13, 2025
10:03 AM EST, 02/13/2025 (MT Newswires) -- International Paper ( IP ) said Thursday it will permanently shutdown multiple facilities in the US by the end of April. The facilities include The Red River containerboard mill in Campti, Louisiana, a recycling plant in Phoenix, Arizona, a box plant in Hazleton, Pennsylvania, and a sheet feeder facility in St. Louis, Missouri....
Copyright 2023-2026 - www.financetom.com All Rights Reserved